Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Applied Clinical Education

Metastatic Prostate Cancer: Current Trends and Future Landscape

Access Activity

Overview / Abstract:

Learning Objectives:

At the completion of this activity, participants should be better able to:

1. Communicate with patients and colleagues about the pathophysiology, risk factors, symptoms, and genetics of prostate cancer.

2. Create individualized treatment plans for patients with prostate cancer based on current screening and staging guidelines and evidence for monotherapy, combination therapy, and sequencing of therapies.

3. Evaluate data for the benefits and risks of current and evolving strategies in the treatment of metastatic prostate cancer.

Expiration

Dec 31, 2017

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Monograph, Online

Credits / Hours

1.0 AMA PRA Category 1 Credit

Accreditation

ACCME

Presenters / Authors / Faculty

Co-Chairs:

Michael A. Carducci, MD
AEGON Professor in Prostate Cancer Research
Associate Center Director for Clinical Research
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medical Institutions
Baltimore, Maryland

David M. Nanus, MD
Mark W. Pasmantier Professor of Hematology
and Oncology in Medicine
Professor of Medicine and Urology
Chief, Division of Hematology and Medical Oncology
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medicine
New York, New York

Activity Specialities / Related Topics

Immunology / Immunosuppression, Oncology / Cancer / Radiation Therapy, Other, Pain Management, Preventive Care, Primary Care, Surgery

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Genzyme, a Sanofi Company

Keywords / Search Terms

Applied Clinical Education metastatic prostate cancer, pathophysiology of prostate cancer, risk factors of prostate cancer, symptoms of prostate cancer, genetics of prostate cancer, individualized treatment plans, current screening and staging , monotherapy, combination therapy, sequencing therapy, health care providers care for patients with metastatic prostate cancer, medical oncologists, hematologists/oncologists, oncology

Access Activity

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.